Utilization of glucose, blood pressure, and lipid lowering medications among people with type II diabetes in the United States, 1999–2010

Abstract Purpose Changes in relation to drug treatment to various control targets for diabetes were studied using the National Health and Nutrition Examination Survey, 1999–2010. Methods Data on 3094 participants aged 20 years or older with diagnosed type II diabetes were analyzed. Use of medication...

Full description

Saved in:
Bibliographic Details
Published in:Annals of epidemiology 2014-07, Vol.24 (7), p.516-521.e1
Main Authors: Wong, Hoi Kin, BSc, MPhil, Ong, Kwok Leung, PhD, Cheung, Ching-Lung, PhD, Cheung, Bernard M.Y., PhD, FRCP
Format: Article
Language:English
Subjects:
Adrenergic beta-Antagonists
Adult
Aged
Aged, 80 and over
Angiotensin Receptor Antagonists
Antihypertensive Agents - therapeutic use
Biomarkers - blood
Blood Glucose - analysis
Blood Glucose - drug effects
Blood Pressure - drug effects
Diabetes
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - epidemiology
Dyslipidemias - blood
Dyslipidemias - drug therapy
Dyslipidemias - epidemiology
Female
Glycated Hemoglobin A - analysis
Humans
Hypertension - drug therapy
Hypertension - epidemiology
Hypertension - physiopathology
Hypoglycemic Agents - therapeutic use
Hypolipidemic Agents - therapeutic use
Insulin - therapeutic use
Internal Medicine
Male
Middle Aged
NHANES
Nutrition Surveys
Outcome Assessment (Health Care)
Practice Patterns, Physicians' - statistics & numerical data
Prescription Drugs - administration & dosage
Prescription medications
Surveys and Questionnaires
United States - epidemiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Purpose Changes in relation to drug treatment to various control targets for diabetes were studied using the National Health and Nutrition Examination Survey, 1999–2010. Methods Data on 3094 participants aged 20 years or older with diagnosed type II diabetes were analyzed. Use of medications for lowering glucose, blood pressure, and lipids in the past month was assessed by questionnaire. Data from two survey cycles were combined together to produce estimates for each 4-year period. Results Usage of metformin increased from 34.8% to 53.8% and was the most prevalent medications during this period ( P  
ISSN:1047-2797
1873-2585
DOI:10.1016/j.annepidem.2014.05.001